QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:BCAB

BioAtla (BCAB) News Today

$1.51
-0.12 (-7.36%)
(As of 10/3/2023 ET)
Compare
Today's Range
$1.50
$1.66
50-Day Range
$1.51
$3.00
52-Week Range
$1.50
$11.73
Volume
246,059 shs
Average Volume
512,721 shs
Market Capitalization
$72.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.83
SourceHeadline
MarketBeat logoBioAtla (NASDAQ:BCAB) Given New $14.00 Price Target at JPMorgan Chase & Co.
americanbankingnews.com - September 26 at 2:46 AM
markets.businessinsider.com logoAnalyst Ratings for BioAtla
markets.businessinsider.com - September 25 at 3:27 PM
MarketBeat logoBioAtla, Inc. (NASDAQ:BCAB) Given Consensus Rating of "Moderate Buy" by Brokerages
americanbankingnews.com - September 25 at 4:20 AM
marketbeat.com logoMYDA Advisors LLC Takes $147,000 Position in BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - September 10 at 5:22 AM
finance.yahoo.com logoBioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 6 at 7:29 PM
marketbeat.com logoBioAtla, Inc. (NASDAQ:BCAB) Receives Consensus Recommendation of "Moderate Buy" from Analysts
marketbeat.com - August 31 at 3:20 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Acquires Shares of 48,614 BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - August 29 at 4:49 AM
marketbeat.com logoQ3 2023 EPS Estimates for BioAtla, Inc. (NASDAQ:BCAB) Lowered by Analyst
marketbeat.com - August 4 at 9:49 AM
finance.yahoo.com logoBioAtla to Participate in Upcoming Investor Conferences in August
finance.yahoo.com - August 3 at 8:18 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Exelixis (EXEL) and Steris (STE)
markets.businessinsider.com - August 3 at 10:16 AM
msn.com logoJP Morgan Maintains BioAtla (BCAB) Overweight Recommendation
msn.com - August 3 at 10:16 AM
msn.com logoJMP Securities Reiterates BioAtla (BCAB) Market Outperform Recommendation
msn.com - August 3 at 10:16 AM
finance.yahoo.com logoBioAtla, Inc. (NASDAQ:BCAB) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 3 at 10:16 AM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on BioAtla (BCAB)
markets.businessinsider.com - August 2 at 8:51 AM
finance.yahoo.com logoBioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
finance.yahoo.com - August 1 at 5:48 PM
marketbeat.com logoBioAtla (BCAB) Scheduled to Post Earnings on Tuesday
marketbeat.com - July 26 at 5:12 PM
finance.yahoo.com logoBioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
finance.yahoo.com - July 25 at 12:14 PM
marketbeat.com logoBioAtla, Inc. (NASDAQ:BCAB) Given Average Rating of "Moderate Buy" by Brokerages
marketbeat.com - July 12 at 4:11 AM
finance.yahoo.com logoWith 51% ownership of the shares, BioAtla, Inc. (NASDAQ:BCAB) is heavily dominated by institutional owners
finance.yahoo.com - July 7 at 7:35 AM
msn.com logoBioAtla (BCAB) Price Target Increased by 9.33% to 16.73
msn.com - July 6 at 8:45 PM
marketbeat.com logoBioAtla, Inc. (NASDAQ:BCAB) Holdings Boosted by Vontobel Holding Ltd.
marketbeat.com - June 28 at 4:43 AM
finance.yahoo.com logoBioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
finance.yahoo.com - June 26 at 8:16 AM
marketbeat.com logoEndurant Capital Management LP Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - June 14 at 12:07 PM
marketbeat.com logoCitigroup Inc. Boosts Position in BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - June 8 at 4:30 AM
finance.yahoo.com logoBioAtla to Participate in the Jefferies Healthcare Conference
finance.yahoo.com - May 31 at 8:20 AM
marketbeat.com logoOpaleye Management Inc. Invests $2.16 Million in BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - May 26 at 2:50 PM
marketbeat.com logoBioAtla, Inc. (NASDAQ:BCAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - May 23 at 4:12 AM
marketbeat.com logoBrokers Issue Forecasts for BioAtla, Inc.'s Q2 2023 Earnings (NASDAQ:BCAB)
marketbeat.com - May 17 at 6:47 AM
msn.com logoJMP Securities Reiterates BioAtla (BCAB) Outperform Recommendation
msn.com - May 16 at 5:08 PM
markets.businessinsider.com logoWhere BioAtla Stands With Analysts
markets.businessinsider.com - May 15 at 12:48 PM
msn.com logoHC Wainwright & Co. Reiterates BioAtla (BCAB) Buy Recommendation
msn.com - May 15 at 12:48 PM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on BioAtla (BCAB)
markets.businessinsider.com - May 15 at 7:47 AM
markets.businessinsider.com logoBioAtla (BCAB) Receives a Buy from JMP Securities
markets.businessinsider.com - May 15 at 2:30 AM
msn.com logoEF Hutton Reiterates BioAtla (BCAB) Buy Recommendation
msn.com - May 13 at 5:37 PM
markets.businessinsider.com logoBioAtla (BCAB) Receives a Buy from BTIG
markets.businessinsider.com - May 12 at 8:52 AM
finance.yahoo.com logoBioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
finance.yahoo.com - May 11 at 10:44 PM
investing.com logoBioatla (BCAB) Earnings Dates & Reports
investing.com - May 11 at 12:43 PM
finance.yahoo.com logoBioAtla to Participate in the JMP Securities Life Sciences Conference
finance.yahoo.com - May 8 at 6:11 PM
finance.yahoo.com logoBioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
finance.yahoo.com - May 4 at 8:52 AM
finance.yahoo.com logoWe Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefully
finance.yahoo.com - April 29 at 2:09 PM
msn.com logoEF Hutton Maintains BioAtla (BCAB) Buy Recommendation
msn.com - April 19 at 7:40 AM
finance.yahoo.com logoBioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 27 at 7:39 AM
markets.businessinsider.com logoJMP Securities Keeps Their Buy Rating on BioAtla (BCAB)
markets.businessinsider.com - March 27 at 1:59 AM
finance.yahoo.com logoBioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
finance.yahoo.com - March 16 at 12:55 PM
marketbeat.com logo795,000 Shares in BioAtla, Inc. (NASDAQ:BCAB) Bought by Eventide Asset Management LLC
marketbeat.com - March 3 at 11:02 AM
finance.yahoo.com logoBioAtla Announces Change in Executive Leadership
finance.yahoo.com - February 27 at 9:38 AM
finance.yahoo.com logoBioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
finance.yahoo.com - February 23 at 1:36 PM
marketbeat.com logoMassachusetts Financial Services Co. MA Grows Position in BioAtla, Inc. (NASDAQ:BCAB)
marketbeat.com - February 15 at 5:15 AM
finance.yahoo.com logoRecent uptick might appease BioAtla, Inc. (NASDAQ:BCAB) institutional owners after losing 56% over the past year
finance.yahoo.com - January 25 at 8:21 AM
marketbeat.com logoBioAtla (NASDAQ:BCAB) Earns Buy Rating from Analysts at EF Hutton Acquisition Co. I
marketbeat.com - January 5 at 8:39 AM
Get BioAtla News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter.



BCAB Media Mentions By Week

BCAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCAB
News Sentiment

0.94

0.70

Average
Medical
News Sentiment

BCAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCAB Articles
This Week

0

1

BCAB Articles
Average Week

Get BioAtla News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BCAB) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -